Results

Total Results: 1,172 records

Showing results for "cancer".
Users also searched for: colon cancer screening

401. Communication and Dissemination Strategies To Facilitate the Use of Health-Related Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-evidence-communication_executive.pdf
     November 01, 2013 - J Natl Cancer Inst. 2008 Mar 5;100(5):347-58. PMID: 18314474. 27. … Improving communication of breast cancer recurrence risk. … Breast Cancer Res Treat. 2012 Jun;133(2):553-61. … Cancer Epidemiol. 2011 Dec;35(6):574-9. PMID: 21622043. 40. … Eur J Cancer. 2010 Aug;46(12): 2267-74. PMID: 20466537. 41.

402. Methods Guide for Medical Test Reviews Chapter 10 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-decision-models_methods.pdf
     July 01, 2012 - Tumor dwell time (an unknown deep parameter in both models) was set to approximately 10 years in MISCAN-COLON … Evaluating new screening tests for breast cancer. BMJ 2006; 332(7543):678-679. 20. … National Cancer Institute, Cancer Intervention and Surveillance Modeling Network. … Endoscopic colorectal cancer screening: a cost-saving analysis. … J Natl Cancer Inst 2000; 92(7):557- 563. 30.

403. White Paper_Living Systematic Reviews: Examining Excluded Full-Text Articles To Better Understand the Evidence Base on Plant-Based Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/living-systematic-reviews-full-text-articles-white-paper.pdf
     January 01, 2024 - Adjunctive Nabilone in cancer pain and symptom management: a prospective observational study using … Concomitant cannabis abuse/dependence in patients treated with opioids for non-cancer pain. … patients with chronic uncontrolled pain Ineligible population Not chronic pain (advanced cancer … Concomitant cannabis abuse/dependence in patients treated with opioids for non-cancer pain. … Adjunctive Nabilone in cancer pain and symptom management: a prospective observational study using

404. PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-mortality-elderly_research.pdf
     March 01, 2009 - Because chlorpromazine and haloperidol can be used as antiemetics for cancer chemotherapy patients … in Canada, patients who had one or more diagnosis of any cancer during the 12 months prior to their … Cancer deaths within 180 days were excluded because such cancers were likely to be preexisting and … may have been associated with conventional APMs used as antiemetics for cancer chemotherapy. … other cardiovascular conditions (e.g., valvular disease, aneurysms, and peripheral vascular disease), cancers

405. Gorman_Asynchronous (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/gorman.pdf
     January 01, 2009 - enabled  Communication… Mark Gorman Director  oÆ Survivorship Policy National Coalition  for Cancer … Silver Spring,  MD Slide 2: About NCCS • Founded  in  1986 • Mission: Advocate for Quality Cancer … Particular focus on  skills patients and  families need  to be  effective  self advocates o Cancer

406. Disposition of Comments Report for Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
     September 15, 2014 - and trend for reduced risk for colorectal cancer. … reported to postmenopausal women who took 1100 IUs of vitamin D daily for 4 years reduced risk of cancers … We have added the post hoc analysis for breast and colorectal cancer and for hip fracture conducted … We have added the data and a discussion of the hip fracture, colorectal cancer, and breast cancer findings … -The cancer data was a secondary outcome -the data in the cancer paper is incomplete because it lacks

407. Naik (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/naik.pdf
     January 01, 2009 - chronic heart disease with   history of coronary artery stent • Now presents with diagnosis of colon cancer … Co-­‐Management Roles o Co-­‐manager with principal care  Oncologist coordinating all aspects of cancer … care o Co-­‐manager with shared care  Medical and surgical oncologist sharing cancer care Slide … Slide 18: Diabetes  in Cancer Care Program • Mr. … Oncologist and endocrinologist co-­‐manage: diabetic patients receiving chemotherapy for colorectal cancer

408. THIS IS OUR TEACHER! (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_media_wilkes.ppt
     April 01, 2006 - Getting tested to detect cancer early is one of the best ways to stay healthy--or is it? … paints HealthNet as a big boogieman that is careless and cheap with regard to women dying of breast cancer … The side effects – hot flashes and other menopause-like symptoms, increased rates of uterine cancer and … – outweighed the slight benefits; In April 2006 the NCI again promised a new drug to prevent breast cancer … raloxifene – claimed it had fewer side effects claimed it could prevent 2 million cases of breast cancer

409. AHRQ Slide Template 2009 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
     March 01, 2010 - In particular, are you wary of using human growth hormone because of its risk of neoplasms? … By and large, the key informants were not concerned about the risk of neoplasms arising from the relatively … ) markers of cancer risk with rhGH (IGF-I increases over 100 ng/ml or IGFBP-3 decreases over 1,000 ng … /ml) from studies of rhGH in people with CF [cystic fibrosis], and (b) assessment of evidence on cancer … growth hormone] use as determined by (a) markers of cancer risk with rhGH (IGF-I [insulin-like growth

410. Association Between Outcomes and Dental Services in People at Risk of Post-Transplant Complications: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-post-transplant-complications-rapid-research.pdf
     May 01, 2025 - complications, including acute and chronic rejections of transplants, organ failures, infections, and malignancies … or anti-cancer treatment, and quality of life. … (2) American Cancer Society. Stem Cell or Bone Marrow Transplant Side Effects. … https://www.cancer.org/cancer/managing- cancer/treatment-types/stem-cell- transplant/transplant-side-effects.html … Health Care Costs among Patients with Hematologic Malignancies Receiving Allogeneic Transplants: A

411. Case-Management Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_executive.pdf
     January 01, 2013 - Low Key Question 1a Cancer Satisfaction with care. … Moderate Key Question 1a Cancer Cancer-related symptoms, functioning, quality of life, survival. … Moderate Key Question 1b Cancer Appropriate treatment. … ) cancer treatment (2 studies). … Low Key Question 1c Cancer Health care expenditures.

412. AHRQ Slide Template 2009 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/presentation.ppt
     August 01, 2009 - Rows represent different cancer types. … Small columns denote outcomes (overall survival, cancer-specific survival, or other outcomes). … Reviews of Selected Pharmacogenetic Tests for Non-Cancer and Cancer Conditions. … Reviews of Selected Pharmacogenetic Tests for Non-Cancer and Cancer Conditions. … Systematic review: charged-particle radiation therapy for cancer. Ann Intern Med 2009;151:556-65.

413. What do we know about how evidence of harm and benefit is communicated in other countries? (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
     January 01, 2005 - Sample sizes generally small Example from Medical Literature (United States) Decision: prostate cancer … Evidence-based patient choice: a prostate cancer decision aid in plain language. … Example from Medical Literature (Northern Ireland) Decision: hormonal therapy for prostate cancer Format … Evaluation of an evidence-based education package for men with prostate cancer on hormonal manipulation

414. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
     March 01, 2024 - A study of hematological cancer patients with moderate/unclear risk of bias53 showed significantly increased … one study with low risk of bias (RR 0.24; CI 0.09, 0.69).34 In contrast, the study of hematological cancer … National Institutes of Health, National Cancer Institute. … 23 Adenocarcinoma pancreas: 1/523, 0/526 RR = 3.02; CI: 0.12 to 73.76 Non-small cell lung cancer … , solid tumor Severity level: Hospitalized and on invasive mechanical ventilation or extracorporeal

415. Abnormal-Uterine-Bleeding Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/abnormal-uterine-bleeding_research-protocol.pdf
     November 21, 2011 - caused by pelvic disease, uterine fibroids, ovarian cysts, endometrial polyps, coagulation disorders, malignancy … criteria detected by imaging, biopsy, or pathology (i.e., PALM: polyps; adenomyosis; leiomyomata; and malignancy … duration, excluding regular cyclic/menstrual patterns of bleeding, fibroids, polyps, adenomyosis, cancers … duration, excluding irregular and unpredictable patterns of bleeding, fibroids, polyps, adenomyosis, cancers … duration, excluding regular cyclic/menstrual patterns of bleeding, fibroids, polyps, adenomyosis, cancers

416. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
     January 01, 2012 - undergoing high-resolution anoscopy with biopsy, 55% of patients had high-grade anal intraepithelial neoplasia … in patients with HIV. 2 A pilot screening program for anal intraepithelial neoplasia in HIV-1 positive … among those undergoing high-resolution anoscopy with biopsy, 55% had high-grade anal intraepithelial neoplasia … in patients with HIV has increased and that a significant unmet need exists to detect these malignancies … evidence existed to determine how effective anal Pap screening would be in reducing the burden of these cancers

417. Minimal Modeling Approaches to Value of Information Analysis for Health Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-value-of-information_research.pdf
     June 01, 2011 - Background and Setting Pancreatic cancer is the fourth most common cause of cancer death in the United … Assessment of human cancer risk: challenges for alternative approaches. … Cancer Statistics, 2008. CA Cancer J Clin 2007;58:71–96. 45. … SEER Cancer Statistics Review, 1975- 2007. Bethesda, MD: National Cancer Institute. … gemcitabine in patients with pancreatic cancer Setting U.S. U.S.

418. Efficacy of Dental Services for Reducing Adverse Events in Those Receiving Chemotherapy for Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/chemotherapy-dental/research

419. Methods Guide for Medical Test Reviews Chapter 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-outcomes_methods.pdf
     July 01, 2012 - screening10 and the American Cancer Society’s recommendations for early cancer detection.11 To illustrate … Guidelines for cervical cancer screening: history and scientific rationale. … Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines … and cancer screening issues. … CA Cancer J Clin 2008;58:161-179.

420. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
     March 09, 2010 - antibodies; biologic Yes Infections Adalimumab Humira TNF inhibitor; biologic Yes Infections; cancer … -1 blocker; biologic No Vertigo Etanercept Enbrel TNF inhibitor; biologic Yes Infections; cancer … Mycophenolate mofetil CellCept Guanosine synthesis inhibitor; nonbiologic No Cancer; bone … Specifically, we will examine mortality, malignancy, serious infection, hepatitis, bone marrow suppression … Outcomes, Timing, Settings RCTs Randomized Controlled Trials TEP Technical Expert Panel TNF Tumor